LRRK2 and Parkinson disease: In a mouse model, the Parkinson disease (PD)-associated mutation in LRRK2 affects excitatory postsynaptic signaling in the hippocampus and LRRK2 kinase activity increases as mice age, suggesting that developmental alterations of excitatory synaptic activity relate to long-term outcomes [53].